STAP-2 interacts with Pyk2 and enhances Pyk2 activity in T-cells

被引:11
|
作者
Saitoh, Kodai [1 ]
Tsuchiya, Takuya [1 ]
Kashiwakura, Jun-ichi [1 ]
Muromoto, Ryuta [1 ]
Kitai, Yuichi [1 ]
Sekine, Yuichi [1 ]
Oritani, Kenji [2 ]
Matsuda, Tadashi [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan
[2] Int Univ Hlth & Welf, Dept Hematol, 4-3 Kouzunomori, Chiba 2868686, Japan
关键词
Pyk2; STAP-2; SDF-l alpha; T-cell; Chemotaxis; TRANSDUCING ADAPTER PROTEIN-2; BREAST-CANCER CELLS; STAT3; ACTIVATION; RECEPTOR; KINASE; CHEMOKINE; PHOSPHORYLATION; TYROSINE-250; CHEMOTAXIS; MODULATION;
D O I
10.1016/j.bbrc.2017.05.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
STAP-2 is an adaptor molecule regulating several signaling pathways, including TLRs and cytokine/chemokine receptors in immune cells. We previously reported that STAP-2 enhances SDF-1 a-induced Vavl/Racl-mediated T-cell chemotaxis. However, the detailed mechanisms of STAP-2 involvement in enhancing T-cell chemotaxis remain unknown. In the present study, we demonstrate that STAP-2 directly interacts with Pyk2, which is a key molecule in the regulation of SDF-la/CXCR4-mediated T-cell chemotaxis, and increases phosphorylation of Pyk2. Pyk2 itself can induce STAP-2 Y250 phosphorylation, and this phosphorylation is critical for maximal interactions between STAP-2 and Pyk2. Finally, SDF-1 a induced T-cell chemotaxis is inhibited by treatment with Pyk2 siRNA or AG17, an inhibitor of Pyk2, in Jurkat cells overexpressing STAP-2. Taken together, the Pyk2/STAP-2 interaction is a novel mechanism to regulate SDF-1 alpha-dependent T-cell chemotaxis. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [21] Specific heterotrimeric binding between PYK2, SHPTP2 and PKC-δ induced by ROS promotes PYK2 activation in VSMCs
    Frank, GD
    Tang, H
    Motley, ED
    Inagami, T
    Eguchi, S
    FASEB JOURNAL, 2001, 15 (04): : A87 - A87
  • [22] PYK2 expression and phosphorylation in neonatal and adult cardiomyocytes
    Bayer, AL
    Ferguson, AG
    Lucchesi, PA
    Samarel, AM
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (05) : 1017 - 1030
  • [23] PYK2 as a Novel Therapeutic Target for Pancreatic Cancer
    Hu, J.
    PANCREAS, 2017, 46 (10) : 1407 - 1407
  • [24] Pyk2 promotes tumor progression in multiple myeloma
    Zhang, Yu
    Moschetta, Michele
    Daisy Huynh
    Tai, Yu-Tzu
    Zhang, Yong
    Zhang, Wenjing
    Mishima, Yuji
    Ring, Jennifer E.
    Tam, Winnie F.
    Xu, Qunli
    Maiso, Patricia
    Reagan, Michaela
    Sahin, Ilyas
    Sacco, Antonio
    Manier, Salomon
    Aljawai, Yosra
    Glavey, Siobhan
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Pachter, Jonathan
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    BLOOD, 2014, 124 (17) : 2675 - 2686
  • [25] Role of PYK2 in the development of obesity and insulin resistance
    Yu, Y
    Ross, SA
    Halseth, AE
    Hollenbach, PW
    Hill, RJ
    Gulve, EA
    Bond, BR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (04) : 1085 - 1091
  • [26] PYK2 at the Intersection of Signaling Pathways in Pancreatic Cancer
    Means, Anna L.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 8 (04): : 651 - 652
  • [27] Inhibition of PYK2 enhances the anti-tumor effect of CD8+T cells in melanoma
    Mizuno, Y.
    Umemura, M.
    Suzuki, F.
    Hayashi, C.
    Nagasako, A.
    Ishikawa, S.
    Yamaguchi, Y.
    Ishikawa, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S106 - S106
  • [28] Regulation of endothelial cell function by Fak and Pyk2
    Orr, AW
    Murphy-Ullrich, JE
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 1254 - 1266
  • [29] Pyk2/MCU Pathway and Treatment of Ischemic Stroke
    Zhang, K.
    Yan, J.
    Wang, L.
    Tian, X.
    Zhang, T.
    Guo, L.
    Li, B.
    Wang, W.
    Liu, X.
    CELL TRANSPLANTATION, 2016, 25 (04) : 778 - 779
  • [30] Pyk2 deficiency enhances bone mass during midpalatal suture expansion
    Sun, Jun
    Eleniste, Pierre P.
    Utreja, Achint
    Turkkahraman, Hakan
    Liu, Sean Shih-Yao
    Bruzzaniti, Angela
    ORTHODONTICS & CRANIOFACIAL RESEARCH, 2020, 23 (04) : 501 - 508